Companies: 10,795·Total market cap: $144.5T
The Oncology Institute, Inc.

The Oncology Institute, Inc.

TOINASDAQHealthcare● Active
$5.07
+$0.20(+4.11%)
Market Cap$506913303
P/E Ratio
52W High$5.575
52W Low$2.015
Overview

The Oncology Institute, Inc.(TOI)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

toi · 股价预测 · 5 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 5 位华尔街分析师

SellBuy

Buy

5 位分析师

共识

评级分布

Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
合计: 5 · 买入占比: 100.0%

12 个月目标价

High

$8.00

Consensus

$8.00

+55.0% upside

Low

$8.00

Median: $8 · Last Close: $5.16

The Oncology Institute, Inc.(TOI)的分析师共识为 Buy,基于过去 3 个月内 5 位华尔街分析师的评级。TOI 的 12 个月平均目标价为 $8.00,相对当前价 $5.16 代表 +55.0% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

Bull

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$5.425.00%

1-day model range: $5.38–$5.46. Peak: $5.46 (+5.00%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$9+79.8%
2028$13+158.7%
2029$17+221.1%
2030$19+263.7%
2031+290.3%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

93%0%7%
13Buy
0Neutral
1Sell
RSI (14)75.2Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · TOI · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$4.72BUY
MA 10$4.70BUY
MA 20$4.42BUY
MA 50$3.83BUY
MA 100$3.38BUY
MA 200$3.50BUY
Current $TOI · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$4.84BUY
EMA 10$4.69BUY
EMA 20$4.46BUY
EMA 50$4.00BUY
EMA 100$3.69BUY
EMA 200$3.38BUY
Current $TOI · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Needham2026-03-13
Maintains
BuyBuy
B. Riley Securities2026-03-13
Maintains
BuyBuy
Needham2026-03-09
Maintains
BuyBuy
BTIG2026-03-09
Maintains
BuyBuy
BTIG2025-10-21
Maintains
BuyBuy
Guggenheim2023-06-16
Maintains
BuyBuy
Guggenheim2023-03-20
Maintains
NeutralNeutral
Guggenheim2022-11-11
Maintains
BuyBuy
Jefferies2022-08-15
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on The Oncology Institute, Inc. (TOI) stock. Of the recent 9 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover TOI.

分析师推荐趋势

Buy ratings14↑ +3
Hold ratings00
Sell ratings00

TOI analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$415M

↓ 36.7% YoY

Revenue Next Year

$501M

↑ 20.7% YoY

EPS This Year

$-0.36

EPS Next Year

$-0.59

↑ 63.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast TOI EPS of $-0.36 for the current fiscal year, based on estimates from 1 analysts. The TOI revenue forecast is $415M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

TOI 股价预测由两类独立数据源支撑:来自 5 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。TOI 的共识目标价为 $8.00(+55.0% 上行空间),分析师共识为 Buy。

TOI 的短期预测(明日)为 $5.42(+5.00%)。 TOI 对 2027 年的股价预测均值为 $9。 TOI 对 2030 年的预测区间为 $17–$20。

The Oncology Institute, Inc. 在 NASDAQ 上市,代码 TOI。TOI 在 2027 年的整体展望偏积极,在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

TOI 预测 · 8 个问题

根据 5 位华尔街分析师,TOI 的 12 个月平均目标价为 $8.00,最高 $8.00、最低 $8.00。若有图表,中位目标价可在上方查看。相对当前价 $5.16,隐含约 +55.0% 的上行空间。

TOI 目标价TOI 分析师目标价TOI 12个月目标价目标价 TOI

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.